APLN and central nervous system cancer: Furthermore, these upregulated miRNAs in APTE were significantly enriched in cancer, glioma, and PI3K-Akt signaling pathways, whereas the downregulated miRNAs observed in CTEPH were mainly enriched in cancer and apelin signaling pathways.